Edward D. Martin, M.D. Accepts Chair of Protokinetix' Business Advisory Board

Ross Senior, President and CEO of ProtoKinetix, Inc., (OTCBB:PKTX) is pleased to announce the appointment of Edward D Martin, M.D. as Chairman of the Business Advisory Board. Dr. Martin has provided valuable advice to ProtoKinetix and has been instrumental in the introduction of AAGP™ to scientists and senior management in the health care industry. ProtoKinetix’ Board and management welcome the wealth of experience that Ed Martin brings to the Company’s future development.

Edward D. Martin, M.D. is the co-founder and Chairman of Martin, Blanck & Associates, Inc., a consulting firm to the health care industry, government, and to major health care information management and technology companies since March of 1998.

From July, 2000 through December, 2004, Dr. Martin was a Senior Vice President and the Chief Medical Officer at Science Applications International Corporation (SAIC) and continues to support SAIC on a part-time basis.

Dr. Martin had a distinguished 30-year career in public service as a commissioned officer in the United States Public Health Service, Department of Health and Human Services, (formerly Department of Health, Education and Welfare). His last assignments were at the Department of Defense (DoD) where he served as the Acting Assistant Secretary of Defense (Health Affairs), and, prior to this appointment, as Principal Deputy Assistant Secretary of Defense (Health Affairs). In the latter position, held from December 1992 to April 1997, Dr. Martin exercised day-to-day executive management and oversight of all Department of Defense (DoD) health policies, programs, and activities within the Military Health System (MHS). The Nation’s second largest health care system, the MHS, delivers care to over 9 million beneficiaries through a worldwide network of more than 500 hospitals and clinics, and provides military beneficiaries with a triple-option health program.

In his two terms as Acting Assistant Secretary of Defense for Health Affairs, from January 1993 to March 1994, and from March 1997 until March 1998, respectively, Dr. Martin assumed responsibility for the overall supervision of the health and medical affairs of the DoD. He also served as the Deputy Assistant Secretary of Defense (Professional Affairs and Quality Assurance) from March 1990 until December 1992.

Dr. Martin arrived at the Pentagon in 1989 after 15 years of executive leadership positions with the Public Health Service (PHS). He served as Chief of Staff for C. Everett Koop, M.D., Surgeon General; Director, Bureau of Health Care Delivery and Assistance; Acting Deputy Administrator, Health Resources and Services Administration; and Director, Bureau of Community Health Services. Dr. Martin was commissioned in the PHS in May 1975 and held the rank of Rear Admiral upon his retirement in April 1998.

A native of Topeka, Kansas, Dr. Martin served for 5 years as a United States Navy Hospital Corpsman prior to completing his undergraduate degree at the University of Kansas in 1966. He received his M.D. degree from the University of Kansas Medical School in 1970 and completed his residency in Pediatrics at the Montefiore Hospital and Medical Center in 1973.

Dr. Martin has written on topics ranging from rural health and primary care initiatives to quality of care. He is the recipient of numerous awards and honors, including two Public Health Service Distinguished Service Medals, the Defense Distinguished Service Medal, and the Secretary of Defense Medal for Meritorious Civilian Service.

Dr. Martin resides in Arlington, Virginia, with his wife, Kathleen, a retired Captain in the Public Health Service, and their two sons, James and William.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX is currently in dialogue with major corporations and institutions who have contacted the company about the broad range of applications for AAGP™ products.

For more detailed information, please visit our website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Ross L. Senior, President and CEO

ProtoKinetix Inc.
Investor Contact
Blair Henderson, 604-687-9887